Revenue Recognition and Contractual Adjustments (Tables)

3 Months Ended

Mar. 31, 2018

Summary of Contract Assets and Liabilities

The following table summarizes the values of contract assets, capitalized commissions and contract liabilities as of March 31, 2018 and December 31, 2017 (in thousands):



	March 31,		December 31,
	2018		2017
Current pharma contract asset	$	821	$	541
Long-term pharma contract asset	140		31
Total pharma contract asset	$	961	$	572

Current pharma capitalized commissions	$	436	$	371
Long-term pharma capitalized commissions	213		171
Total pharma capitalized commissions	$	649	$	542

Current pharma contract liability	$	2,193	$	1,406
Long-term pharma contract liability	522		283
Total pharma contract liability	$	2,715	$	1,689

Summary of Disaggregation of Revenue

The following table details the disaggregation of revenue for both the Clinical and Pharma Services Segments (in thousands):



	Three Months Ended March 31,
	2018		2017
Clinical Services:
Client direct billing	$	38,530	$	33,630
Commercial Insurance	10,326		11,436
Medicare and Medicaid	8,084		7,818
Self-Pay	31		22
Total Clinical Services	$	56,971	$	52,906
Pharma Services:	6,452		4,521
Total Revenue	$	63,423	$	57,427